Mobile money and households' ability to respond to health shocks in Africa: Evidence from Madagascar [0.03%]
移动支付与非洲家庭应对健康冲击的能力——来自马达加斯加的证据
Gbêtondji Melaine Armel Nonvide
Gbêtondji Melaine Armel Nonvide
Promoting the use of mobile money seems to be an important way of improving financial inclusion and households ability to cope with health shocks. This study aims to analyze the impact of mobile money usage on households ability to respond ...
Cost-effectiveness analysis of influenza vaccination with high-dose vaccine versus standard-dose quadrivalent vaccine in older adults in Spain [0.03%]
西班牙老年人群体中高剂量与标准剂量四价流感疫苗的疗效及成本分析研究
Jose-Maria Abellan-Perpiñan,Esther Redondo Margüello,Ángel Gil de Miguel et al.
Jose-Maria Abellan-Perpiñan et al.
Introduction and objectives: Influenza is a widespread acute respiratory illness which represents a significant public health challenge from both the National Health Service (NHS) and societal perspective, especially in t...
Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany [0.03%]
德国多中心真实世界研究中allo-HSCT后接受莱特莫韦预防CMV患者的医疗资源利用和成本分析
Marie Engelhard,Sebastian M Wingen-Heimann,Annika Y Classen et al.
Marie Engelhard et al.
Objectives: Letermovir has demonstrated efficacy and tolerability as prophylaxis against clinically significant cytomegalovirus infection (csCMVi) in CMV-seropositive adult patients undergoing allogeneic hematopoietic cel...
Repurposing biosimilars, rethinking costs: a framework for sustainable drug pricing for repurposed bevacizumab for intravitreal injections [0.03%]
重构贝伐单抗生物类似药的用途，重新思考成本：玻璃体内注射重组贝伐单抗可持续药物定价框架
Evert A Manders,Vincent van Der Wel,Reinier Schlingemann et al.
Evert A Manders et al.
Bevacizumab, originally developed by Genentech under the brand name Avastin® as an anti-cancer drug, has gained widespread off-label use in ophthalmology due to its similar mechanism of action to other anti-VEGF treatments and its signific...
Promoting healthy behaviour with financial incentives: three challenges and solutions for large scale implementation [0.03%]
用经济激励促进健康行为：大规模实施中的三大挑战和解决办法
Stefan A Lipman,David R de Buisonjé,Koen van der Swaluw
Stefan A Lipman
Financial incentives are a promising intervention to promote healthier behaviours and potentially reduce health inequalities. Despite robust evidence supporting their effectiveness in encouraging actions such as smoking cessation, increased...
Healthcare cost for non-hospital services and pharmaceuticals among breast cancer survivors: an event study [0.03%]
乳腺癌幸存者的非住院服务和药品医疗成本：一项事件研究
Aarushi Dhingra,Brenda Gannon,Terence C Cheng et al.
Aarushi Dhingra et al.
Breast cancer survivors require continuing long-term care, which leads to substantial resource use and subsequently increased healthcare costs (HC), having an impact on both the individual and society. This paper aims to investigate the imp...
Predicting EuroQol (EQ-5D-5 L) health state utilities from functional outcomes of sleep questionnaire (FOSQ-10) scores [0.03%]
利用功能睡眠问卷(FOSQ-10)预测EuroQol(EQ-5D-5L)健康状态效用分数
Andrea N Natsky,Ching Li Chai-Coetzer,Andrew Vakulin et al.
Andrea N Natsky et al.
Are there longer-term costs of informal care? Understanding post-care wellbeing and labour market participation outcomes [0.03%]
长期的无正式合同护理的成本有哪些？理解护理后的健康和劳动力市场参与情况
Wai-Man Liu,Emma Schultz,Aaron Bruhn
Wai-Man Liu
While a substantial body of empirical research documents the negative wellbeing and labour force participation effects of transitioning into and maintaining informal care roles, studies of transitions out of caregiving are small in number a...
Gemma Garrido-Alejos,Anna Feliu,Daniel Gay-Pérez et al.
Gemma Garrido-Alejos et al.
Objectives: The treatment of multiple myeloma (MM) has changed substantially in the last two decades due to many therapeutic innovations. This study aims to analyse the authorization trends of drug regimens for the treatm...
Assessing the costs and benefits of non-pharmaceutical pandemic measures using the economic values of social contacts [0.03%]
基于社交活动的经济价值评估大流行非药物干预措施的成本和效益
Mortaza Baky Haskuee,Ali Asgary,Zachary McCarthy et al.
Mortaza Baky Haskuee et al.
We develop and calibrate a two-layer macroeconomic model of a pandemic to examine the macroeconomic costs and benefits of COVID-19 public health interventions. By integrating policies into a stratified epidemic compartmental model (Suscepti...